当前位置: 首页 >> 检索结果
共有 4802 条符合本次的查询结果, 用时 2.3393764 秒

1041. Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease.

作者: Jennifer R Hannah.;Alexandra Lawrence.;Jennifer Martinovic.;Marium Naqvi.;Felix Chua.;Vasileios Kouranos.;Saadia Sasha Ali.;Carmel Stock.;Cara Owens.;Anand Devaraj.;Louise Pollard.;Sangita Agarwal.;Belén Atienza-Mateo.;Miguel Angel González-Gay.;Amit Patel.;Alex West.;Kate Tinsley.;Hasti Robbie.;Boris Lams.;Athol U Wells.;Sam Norton.;James Galloway.;Elisabetta A Renzoni.;Patrick A Gordon.
来源: Rheumatology (Oxford). 2024年63卷11期3080-3090页
The impact of autoantibody profiles on the prognosis for idiopathic inflammatory myositis-associated interstitial lung disease (IIM-ILD) and myositis spectrum ILD with myositis-specific antibodies (MSAs) remains unclear. This retrospective cohort study examined whether serological profiles were associated with mortality or longitudinal lung function change.

1042. Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity.

作者: Emil Rydell.;Lennart Th Jacobsson.;Tore Saxne.;Carl Turesson.
来源: BMC Rheumatol. 2023年7卷1期43页
To investigate whether baseline serum cartilage oligomeric matrix protein (COMP), patient characteristics, traditional cardiovascular disease (CVD) risk factors and disease activity over time predict CVD, in early rheumatoid arthritis (RA).

1043. Osteonecrosis as a rare musculoskeletal complication in Behcet's disease- the largest case series with literature review.

作者: Mohammad Nejadhosseinian.;Mazyar Babagoli.;Seyedeh Tahererh Faezi.;Hoda Haerian.;Farhad Shahram.;Majid Alikhani.;Fereydoun Davatchi.
来源: BMC Rheumatol. 2023年7卷1期42页
Behcet disease (BD) as a variable vessel vasculitis is mainly characterized by ocular involvement, genital and oral aphthosis, and erythema nodosum. However, major organ involvements including gastrointestinal involvement, nervous system, and vascular involvement are among the severe complications. Osteonecrosis is a rare complication of patients with BD. We aim to report the largest series of BD patients suffering from osteonecrosis.

1044. Predicting treatment response to methotrexate: are we closer to solving the enigma?

作者: Elena Myasoedova.
来源: Rheumatology (Oxford). 2024年63卷6期1479-1480页

1045. Colchicine: the good, the bad, the ugly and how to minimize the risks.

作者: Lisa K Stamp.;Carl Horsley.;Leanne Te Karu.;Nicola Dalbeth.;Murray Barclay.
来源: Rheumatology (Oxford). 2024年63卷4期936-944页
Colchicine has an important role in managing various conditions, including gout, familial Mediterranean fever, amyloidosis, Behçet's syndrome, recurrent pericarditis and calcium pyrophosphate deposition disease. The adverse effect profile of colchicine is well understood. However, due to its narrow therapeutic index, colchicine has been associated with overdose and fatalities. When ingested in toxic amounts, the mainstay of management is supportive care. Strategies to minimize the risk of colchicine poisoning can focus on three broad causes: unauthorized access, intentional overdose and inappropriate dosing. Culturally safe and appropriate education about storage and appropriate use of colchicine is essential to minimize the risk of overdose.

1046. An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis.

作者: Lily Watson.;Conor Coyle.;Caroline Whately-Smith.;Melanie Brooke.;Uta Kiltz.;Ennio Lubrano.;Rubén Queiro.;David Trigos.;Jan Brandt-Juergens.;Ernest Choy.;Salvatore D'Angelo.;Andrea Delle Sedie.;Emmanuelle Dernis.;Sandrine Guis.;Philip Helliwell.;Pauline Ho.;Axel J Hueber.;Beatriz Joven.;Michaela Koehm.;Carlos Montilla.;Jon Packham.;José Antonio Pinto Tasende.;Felipe Julio Ramirez Garcia.;Adeline Ruyssen-Witrand.;Rossana Scrivo.;Sarah Twigg.;Martin Soubrier.;Théo Wirth.;Laure Gossec.;Laura C Coates.
来源: Rheumatology (Oxford). 2024年63卷12期3449-3456页
Shared decision-making (SDM) is advocated to improve patient outcomes in PsA. We analysed current prescribing practices and the extent of SDM in PsA across Europe.

1047. Genetic testing of Behçet's disease using next-generation sequencing to identify monogenic mimics and HLA-B*51.

作者: Alice Burleigh.;Ebun Omoyinmi.;Charalampia Papadopoulou.;Eslam Al-Abadi.;Ying Hong.;Fiona Price-Kuehne.;Elena Moraitis.;Hannah Titheradge.;Francesca Montesi.;Diane Xu.;Despina Eleftheriou.;Paul Brogan.
来源: Rheumatology (Oxford). 2024年63卷12期3457-3470页
Several monogenic autoinflammatory disorders and primary immunodeficiencies can present early in life with features that may be mistaken for Behçet's disease (BD). We aimed to develop a genetic analysis workflow to identify rare monogenic BD-like diseases and establish the contribution of HLA haplotype in a cohort of patients from the UK.

1048. Multimorbidity in systemic lupus erythematosus in a population-based cohort: the Lupus Midwest Network.

作者: Gabriel Figueroa-Parra.;Jose A Meade-Aguilar.;Cassondra A Hulshizer.;Tina M Gunderson.;Alanna M Chamberlain.;Uma Thanarajasingam.;Kurt J Greenlund.;Kamil E Barbour.;Cynthia S Crowson.;Alí Duarte-García.
来源: Rheumatology (Oxford). 2024年63卷11期3056-3064页
The objectives of this study were to assess the prevalence and incidence of multimorbidity and its association with the SLICC/ACR damage index (SDI) among patients with SLE.

1049. Characterization of digital annular pulleys and their entheses: an ultrasonographic study with anatomical and histological correlations.

作者: Luis Coronel.;Peter Mandl.;Maribel Miguel-Pérez.;Joan Blasi.;Maria Antonietta D'Agostino.;Carlo Martinoli.;David A Bong.;Ingrid Möller.
来源: Rheumatology (Oxford). 2024年63卷11期3050-3055页
Digital annular pulleys (DAPs) are important anatomical structures for finger function. The anatomy, histology and imaging assessment of DAPs, particularly at the level of their entheses, are still not clearly defined. The advent of high-frequency US transducers opened new perspectives in evaluating submillimetre-scale structures, such as pulleys, paving the way for their global assessment. The study aimed to characterize DAPs from an anatomical, histological and US perspective, focusing on the detection and complete description of pulley entheses.

1050. Validation of the PEDiatric Behçet's Disease classification criteria: an evidence-based approach.

作者: Caterina Matucci-Cerinic.;Helene Palluy.;Sulaiman M Al-Mayouf.;Paul A Brogan.;Luca Cantarini.;Ahmet Gul.;Ozgur Kasapcopur.;Jasmin Kuemmerle-Deschner.;Seza Ozen.;David Saadoun.;Farhad Shahram.;Francesca Bovis.;Eugenia Mosci.;Nicolino Ruperto.;Marco Gattorno.;Isabelle Kone-Paut.
来源: Rheumatology (Oxford). 2024年63卷12期3422-3431页
To validate the PEDiatric Behçet's Disease classification criteria (PEDBD) with an evidence-based approach.

1051. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.

作者: Xia Lyu.;Latika Gupta.;Eleni Tholouli.;Hector Chinoy.
来源: Rheumatology (Oxford). 2024年63卷5期1206-1216页
Chimeric antigen receptor T cell (CAR-T) therapy, an innovative immune cell therapy, has revolutionized the treatment landscape of haematological malignancies. The past 2 years has witnessed the successful application of CD19-targeting CAR constructs in refractory cases of autoimmune rheumatic diseases, including systemic lupus erythematosus, systemic sclerosis and anti-synthetase syndrome. In comparison with existing B cell depletion therapies, targeting CD19 has demonstrated a more rapid and profound therapeutic effect, enabling drug-free remission with manageable adverse events. These promising results necessitate validation through long-term, large-sample randomized controlled studies. Corroborating the role of CAR-T therapy in refractory rheumatological disorders and affirming safety, efficacy and durability of responses are the aims of future clinical studies. Optimizing the engineering strategies and better patient selection are also critical to further refining the successful clinical implementation of CAR-T therapy.

1052. IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study.

作者: Sizheng Steven Zhao.;Matthew C Baker.;James B Galloway.
来源: Rheumatology (Oxford). 2024年63卷4期e118-e119页

1053. Temporomandibular joint disorders in seronegative spondyloarthritis: what a rheumatologist needs to know?

作者: Vasiliki Syrmou.;Maria G Grammatikopoulou.;Dimitrios P Bogdanos.;Konstantinos T Mitsimponas.
来源: Reumatologia. 2023年61卷5期375-388页
Temporomandibular joint (TMJ) can be affected in the context of spondyloarthritis (SpA) with detrimental impact on individuals' quality of life. Intra-articular inflammation, synovitis, enthesitis, disc displacement and cervical vertebrae malalignment are some of the pathophysiological phenomena involved. Temporomandibular joint disorders (TMD) incidence appears to be higher in patients with ankylosing spondylitis and psoriatic arthritis, especially when clinical evaluation includes not only imaging but relevant history, TMJ examination and diagnostic criteria for TMD. The Visual Analogue Scale (VAS) pain score and Health Assessment Questionnaire Disability Index (HAQ) quality of life score could be useful tools. Panoramic radiographs and ultrasound can be used for screening but in symptomatic patients magnetic resonance imaging (MRI) is preferable. Conservative management and early pharmacological treatment can prevent permanent joint impairment. For refractory cases, early referral to Legislation for Oral and Maxillofacial Surgery (OMFS) specialists is indicated. The aim of this narrative review is to address the involvement of TMJ in SpA and to encourage clinicians to incorporate TMJ assessment in their physical examination and basic screening.

1054. Depression, anxiety, and quality of life in patients with systemic lupus erythematosus.

作者: Ali Dehghan.;Hamidreza Soltani.;Seyedeh Tahereh Faezi.;Azarakhsh Baghdadi.;Hossein Soleymani Salehabadi.;Hamidreza Bashiri.;Roya Hemayati.;Mehrdad Mansouri.;Mohammad Motaghi.;Mohammad Nejadhosseinian.
来源: Reumatologia. 2023年61卷5期368-374页
Systemic lupus erythematosus (SLE) is a multisystem disorder that can affect multiple organs; psychiatric manifestations including depression and anxiety are commonly seen in SLE. The aim of this study is to explore the prevalence of depression, anxiety, and stress, and assess the quality of life (QOL) in patients with SLE and also evaluate associated risk factors.

1055. The perspective of Polish patients with rheumatoid arthritis - treatment expectations, patient-reported outcomes, and digital literacy (the SENSE study).

作者: Marcin Stajszczyk.;Grażyna Świerkowska.;Katarzyna Smolik.;Izabela Domysławska.;Karol Charkiewicz.;Włodzimierz Samborski.
来源: Reumatologia. 2023年61卷5期331-338页
A widely accepted treat-to-target strategy for rheumatoid arthritis (RA) requires the patient's perspective in making treatment decisions. However, data on treatment preferences and expectations of Polish patients with RA are scarce. The aim of the study was to determine the satisfaction with treatment and the nature of therapeutic preferences and expectations of Polish patients with moderate to severe RA.

1056. Molecular mechanisms and potential applications of chondroitin sulphate in managing post-traumatic osteoarthritis.

作者: Iryna Golovach.;Dmytro Rekalov.;Oleh Ye Akimov.;Heorhii Kostenko.;Viktoriia Kostenko.;Artur Mishchenko.;Natalia Solovyova.;Vitalii Kostenko.
来源: Reumatologia. 2023年61卷5期395-407页
Post-traumatic osteoarthritis (PTOA), a disorder of the synovium, subchondral bone, and cartilage that affects the entire joint, constitutes approximately 12% of all cases of symptomatic osteoarthritis. This review summarizes the pathogenetic mechanisms that underlie the positive influence of chondroitin sulphates (CSs) on PTOA as means of preventive and therapeutic treatment. Mechanisms of PTOA development involve chondrocytes undergoing various forms of cell death (apoptosis, pyroptosis, necroptosis, ferroptosis and/or necrosis). Chondroitin sulphates are a class of glycosaminoglycans that improve the structure and function of cartilage and subchondral bone, which is associated with their ability to decrease the activation of NF-κB and p38 MAPK, and up-regulate Nrf2. Standardized small fish extract (SSFE) is an example of the drugs that can attenuate NF-κB-mediated systemic inflammation, potentially helping to reduce joint inflammation and cartilage degradation, improve joint function, and alleviate pain and disability in patients with these conditions.

1057. Peculiarities of clinical signs, course and treatment of musculoskeletal system lesions in post-COVID syndrome.

作者: Larysa Voloshyna.;Svitlana Smiyan.;Oleksandr Voloshyn.;Inna Buzdugan.;Olga Bukach.;Natalia Voloshynovych.;Oleksandra Doholich.
来源: Reumatologia. 2023年61卷5期339-344页
Post-COVID syndrome (PCS) is a frequent phenomenon of patients who have suffered from an acute attack of COVID-19 infection, and it is characterized by a wide range of symptoms from different organs and systems including the musculoskeletal system (MSS). However, peculiarities of MSS lesions have not been sufficiently studied to date, in particular, in the aspect of the therapeutic process. We aimed to investigate peculiarities of MSS lesions in patients with PCS.

1058. Ocular involvement in rheumatic diseases.

作者: Iwona Dankiewicz-Fares.;Daniel Jeka.;Tacjana Barczyńska.
来源: Reumatologia. 2023年61卷5期389-394页
Rheumatic diseases are associated with a significant decline in quality of life, which is not only related to the progression of the underlying disease but also to the development of coexisting conditions. One of the possible complications in this group of diseases is ocular involvement. Impaired vision is strongly associated with a significant decline in quality of life and can also exacerbate problems related to physical functioning. Consequently, it can lead to serious complications in the treatment of the underlying disease. Additionally, from a clinical point of view, it is also important to note that ocular diseases may precede the occurrence of inflammatory joint and spinal diseases, as well as organ involvement in systemic connective tissue disorders. Therefore, paying attention to ocular symptoms can help in early diagnosis and thus improve patient prognosis. For the aforementioned reasons, ocular diseases should be carefully considered in routine rheumatologic practice.

1059. Epidemiology of low back pain: frequency, risk factors, and patterns in South-South Nigeria.

作者: Airenakho Emorinken.;Cyril Oshomah Erameh.;Blessyn Omoye Akpasubi.;Mercy Ofunami Dic-Ijiewere.;Asuwemhe Johnson Ugheoke.
来源: Reumatologia. 2023年61卷5期360-367页
Low back pain (LBP) is a prevalent musculoskeletal condition that poses significant public health challenges. However, its epidemiology in Sub-Saharan Africa, especially in rural settings, remains largely unexplored. This study aimed to determine the epidemiology of LBP in a Nigerian Teaching Hospital.

1060. Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update.

作者: Ciro Manzo.;Alberto Castagna.;Arvind Nune.;Marco Isetta.
来源: Reumatologia. 2023年61卷5期408-409页
共有 4802 条符合本次的查询结果, 用时 2.3393764 秒